Exenatide PD3 - Latest info : The protocol... - Cure Parkinson's

Cure Parkinson's

25,540 members26,862 posts

Exenatide PD3 - Latest info

Farooqji profile image
2 Replies

The protocol of the ‘Exenatide-PD3’ study has been published - An ongoing multicentre, double blind, parallel group, placebo controlled, Phase 3 clinical trial is assessing once weekly Bydureon treatment in Parkinsons over 2yrs

bmjopen.bmj.com/content/11/...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
JANVAN profile image
JANVAN

Thanks Farooqji (former I.... I guess) !!

Also in a interesting monthly program on Dutch television (Parkinson TV), the

neurologist professor Bas Bloem, mentioned moderate enthusiastic about the

"reproposal" use of existing drugs. (also Ambroxol).

And he was really satisfied about the "setting up" of I a study in UK

(and I think he was referring to this one).

He mentioned also FUS and stem cell therapy, but emphasized that this doesn't

eliminate the main cause of Parkinson.....

Did you also read the post some days ago about that study in China (with only

11 people, but otherwise good protocol) about "microbiom transplant" ??

gaga1958 profile image
gaga1958

I could easily have missed it, but do you know which centers are conducting the study?

You may also like...

Science of Parkinson's - Exenatide

difference between the liraglutide treated group and the placebo group when the investigators...

Experience with giving oneself a shot? Exenatide shot leaking - medicine being lost - please help

I take 2 mg of Exenatide a week for my PD. (There are many other threads explaining why) About 1/2...

Exenatide : any non diabetic users? Update from those using for diabetes with PD?

was just prescribed Exenatide by my neurologist. He has faith in the Exenatide trial and has...

Anyone have info or opinion on this?

consultation. Any experience or knowledge about this clinic?

PQQ combined with Ubiquinol - info and experience?